GGrantIndex
← Leaderboards

Ventria Bioscience

Fort Collins, CO

Compare ↔
$7,926,416
Total funding
19
Grants

Funding over time

peak $1.8M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$7,926,416 · 19

By mechanism

R44$5,452,121 · 5
R43$2,272,375 · 13
R41$201,920 · 1

Investigators at Ventria Bioscience

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Robust, defined, animal-free cell culture medium for the production of vaccines$826,938
R44 · FY2013 · AI
Robust, defined, animal-free cell culture medium for the production of vaccines$689,933
R44 · FY2012 · AI
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult$538,324
R44 · FY2010 · AG
Production of OspA in rice for the control of Lyme disease$455,157
R44 · FY2010 · AI
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult$420,843
R44 · FY2012 · AG
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult$413,160
R44 · FY2011 · AG
Recombinant production of human transferrin for cell culture$403,361
R44 · FY2011 · GM
Recombinant production of human transferrin for cell culture$396,297
R44 · FY2010 · GM
Recombinant Human Serum Albumin for Use in Cell Culture$377,948
R44 · FY2010 · GM
Recombinant Human Serum Albumin for Use in Cell Culture$346,680
R44 · FY2009 · GM
Oral rice-derived lactoferrin reduced the severity of Crohn's disease through anti-inflammatory regulation of T cells$307,506
R43 · FY2015 · AI
Production of OspA in rice for the control of Lyme disease$296,879
R44 · FY2011 · AI
Production of OspA in rice for the control of Lyme disease$286,601
R44 · FY2012 · AI
Low-cost production of rApoA-IM for the treatment of cardiovascular disease$260,890
R43 · FY2014 · HL
Production of human MUC17 (CRD1-L-CRD2) recombinant protein in rice for the treat$237,323
R43 · FY2013 · DK
Low-cost proinsulin-transferrin fusion protein in rice for treatment of diabetes$232,527
R43 · FY2013 · DK
Low cost production of rabies virus antigens in rice grain$226,554
R43 · FY2011 · AI
Human Lactoferrin in Acetaminophen Overdose-Induced Liver Failure$201,920
R41 · FY2012 · AA
Recombinant human defensin for management of ileal Crohn's disease$189,300
R43 · FY2006 · AI
Robust, animal-free cell culture medium for the production of vaccines$158,820
R43 · FY2011 · AI